Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $50.10 and last traded at $46.74, with a volume of 10866167 shares trading hands. The stock had previously closed at $22.00. Wall Street Analyst Weigh In INSM has been the […]
Insmed Incorporated (NASDAQ:INSM) shares are trading higher after the company released topline results from the ASPEN Phase 3 study of brensocatib in patients with non-cystic fibrosis bronchiectasis. Non–cystic fibrosis bronchiectasis is a chronic inflammatory condition of the lungs associated with respiratory infections, daily coughing, and sputum. The study met its primary endpoint, with both dosage strengths of brensocatib demonstrating statistically significant reductions in the annualized r